DeepMed Research

Cincinnati Children's Hospital Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1883-01-01

Employees: 10K

Market Cap: -

Website: http://www.cincinnatichildrens.org

Clinical Trials

Comparing School Based Interventions for Adolescents With Attention Deficit Hyperactivity Disorder

Phase 2

Completed

Conditions: Attention Deficit Disorder With Hyperactivity

Interventions: Behavioral: Challenging Horizons Program (CHP) consultation model
Behavioral: Challenging Horizons Program (CHP) after-school model

First Posted Date: 2009-07-28

Last Posted Date: 2016-12-16

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 315

Registration Number: NCT00947973

Locations: 🇺🇸
Ohio University, Athens, Ohio, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Center for ADHD, Cincinnati, Ohio, United States

J-Tip® Jet Injection of 1% Buffered Lidocaine or Saline Versus 4% Lidocaine Cream Before Venipuncture or IV Insertion

Early Phase 1

Withdrawn

Conditions: Pain

Interventions: Device: J-Tip jet injector
Device: Jet injection saline
Drug: lidocaine cream

First Posted Date: 2009-06-19

Last Posted Date: 2020-09-21

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Registration Number: NCT00924963

Locations: 🇺🇸
Cincinnati Children's Hospital Liberty Township Emergency Department, Liberty Township, Ohio, United States

Lactobacillus GG in Pediatric Ulcerative Colitis (UC)

Phase 2

Withdrawn

Conditions: Ulcerative Colitis

First Posted Date: 2009-05-08

Last Posted Date: 2017-02-07

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Registration Number: NCT00895336

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Two Anesthetic Techniques in Magnetic Resonance Imaging (MRI)

Phase 1

Terminated

Conditions: Magnetic Resonance Imaging
Anesthesia

Interventions: Drug: propofol
Drug: dexmedetomidine

First Posted Date: 2009-05-07

Last Posted Date: 2020-09-21

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 98

Registration Number: NCT00894751

Locations: 🇺🇸
Cincinnati Children's Medical Center, Cincinnati, Ohio, United States

Liq-NOL Efficacy in Pediatric Patients With Down Syndrome

Phase 2

Withdrawn

Conditions: Down Syndrome

Interventions: Dietary Supplement: Ubiquinol-10 Syrup
Dietary Supplement: syrup (placebo)

First Posted Date: 2009-05-01

Last Posted Date: 2020-09-09

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Registration Number: NCT00891917

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas

Early Phase 1

Completed

Conditions: Newly Diagnosed High-Grade Gliomas
Diffuse Intrinsic Pontine Glioma

Interventions: Drug: Temozolomide
Drug: Bevacizumab
Drug: Irinotecan

First Posted Date: 2009-04-30

Last Posted Date: 2018-05-02

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 27

Registration Number: NCT00890786

Locations: 🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)

Phase 1

Completed

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Behavioral: Sleep Intervention
Drug: Melatonin

First Posted Date: 2009-03-23

Last Posted Date: 2012-03-16

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 8

Registration Number: NCT00867451

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Alternate Day Micafungin: A PK Study in Pediatric Patients

Phase 1

Completed

Conditions: Fungal Infection

Interventions: Drug: Micafungin

First Posted Date: 2009-02-12

Last Posted Date: 2012-02-16

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 15

Registration Number: NCT00842504

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

Phase 1

Completed

Conditions: Tuberous Sclerosis
Angiolipoma

Interventions: Drug: everolimus (RAD001)

First Posted Date: 2008-11-18

Last Posted Date: 2013-09-18

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 20

Registration Number: NCT00792766

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA

Phase 4

Completed

Conditions: Juvenile Idiopathic Arthritis

Interventions: Other: Withdrawal of anti-TNF therapy

First Posted Date: 2008-11-17

Last Posted Date: 2016-04-15

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 137

Registration Number: NCT00792233

Locations: 🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States

and more 13 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy